CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - SEX DIFFERENCE IN 6-MERCAPTOPURINE UTILIZATION

被引：36

作者：

LILLEYMAN, JS ^{[1
]}

LENNARD, L ^{[1
]}

REES, CA ^{[1
]}

MORGAN, G ^{[1
]}

MADDOCKS, JL ^{[1
]}

机构：

[1] ROYAL HALLAMSHIRE HOSP,DEPT THERAPEUT,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1984年 / 49卷 / 06期

关键词：

D O I：

10.1038/bjc.1984.111

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：703 / 707

页数：5

共 14 条

[1] ASSAY OF THIOINOSINIC ACID, AN ACTIVE METABOLITE OF AZATHIOPRINE, IN HUMAN-LYMPHOCYTES [J].

FLETCHER, L ;

MADDOCKS, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :287-292

[2] REAPPRAISAL OF THE RESULTS OF STOPPING THERAPY IN CHILDHOOD LEUKEMIA [J].

GEORGE, SL ;

AUR, RJA ;

MAUER, AM ;

SIMONE, JV .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) :269-273

[3] IMMUNOLOGICALLY DEFINED SUBCLASSES OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - THEIR RELATIONSHIP TO PRESENTATION FEATURES AND PROGNOSIS [J].

GREAVES, MF ;

JANOSSY, G ;

PETO, J ;

KAY, H .

BRITISH JOURNAL OF HAEMATOLOGY, 1981, 48 (02) :179-197

[4]

HEINZ G, 1982, KLIN PAEDIAT, V194, P195

[5] 6-MERCAPTOPURINE - APPARENT LACK OF RELATION BETWEEN PRESCRIBED DOSE AND BIOLOGICAL EFFECT IN CHILDREN WITH LEUKEMIA [J].

HERBER, S ;

LENNARD, L ;

LILLEYMAN, JS ;

MADDOCKS, J .

BRITISH JOURNAL OF CANCER, 1982, 46 (01) :138-141

[6]

JAMES J, 1979, 51ST BRIT PAED ASS A, P90

[7] ASSAY OF 6-THIOGUANINE NUCLEOTIDE, A MAJOR METABOLITE OF AZATHIOPRINE, 6-MERCAPTOPURINE AND 6-THIOGUANINE, IN HUMAN RED-BLOOD-CELLS [J].

LENNARD, L ;

MADDOCKS, JL .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (01) :15-18

[8]

PINKEL D, 1979, CANCER, V43, P1128, DOI 10.1002/1097-0142(197903)43:3<1128::AID-CNCR2820430352>3.0.CO

[9]

2-Y

[10]

REES CA, 1984, CANCER CHEMOTH PHARM, V12, P87

← 1 2 →